Global Pharmaceutical Intermediates Market Size, Share, Growth Analysis, By Product(Chemical intermediates, Bulk drug intermediates), By Application(Analgesics, Anti-inflammatory drug)

Description

Global Pharmaceutical Intermediates Market size was valued at USD 29 billion in 2021 and is poised to grow from USD 30.6 billion in 2022 to USD 52.6 billion by 2030, growing at a CAGR of 6.3% in the forecast period (2023-2030).

Pharmaceutical intermediates play a crucial role as raw materials in the production of bulk drugs. These intermediates are formed during the synthesis of active pharmaceutical ingredients (APIs) before further processing. They are derived from high-quality basic ingredients and find extensive applications in the pharmaceutical and cosmetic industries. The global market for pharmaceutical intermediates is experiencing growth due to the rising demand in these sectors, particularly for research and development purposes.

These intermediates are essential in the manufacturing of various products, including pesticides, drugs, resins, additives, plasticizers, and more, using materials like coal tar or petroleum. The market's expansion is primarily driven by the increased production of active pharmaceutical ingredients, responding to the growing demand for advanced therapies with improved delivery systems and personalized medicines worldwide.

Despite the positive outlook, the industry faces challenges such as the high cost of acquiring biopharmaceutical drugs and substantial apital investments required for API production. However, the introduction of new technologies in pharmaceutical manufacturing and increased investment in research activities are expected to create promising growth opportunities in the coming years.

Segments covered in this report:

Global pharmaceutical intermediates market is segmented on the basis of product, application, and region. On the basis of product, global market is segmented into chemical intermediates, bulk drug intermediates and custom intermediates. On the basis of application, global market is segmented into, analgesics, anti-inflammatory drug, cardiovascular drugs, anti-diabetic drugs and anti-cancer drugs. On the basis of region, global market is divided into North America, Europe, Asia Pacific, Latin America, and MEA.

Driver

The rising prevalence of chronic diseases and the global aging population are significant factors contributing to an increased demand for drug formulations to manage these conditions. According to the World Health Organization (WHO), the cases of diabetes have escalated from 108.0 million in 1980 to 422.0 million in 2014, with a continuous upward trend. Additionally, the WHO predicts a 57% increase in the incidence of chronic diseases by 2020, signifying a substantial portion of the population being affected by these conditions. As a result, the pharmaceutical market is witnessing growth during the forecast period due to these driving factors.

Restraint

The global pharmaceutical intermediates market faces challenges to its growth due to two significant factors. Firstly, the high expenses associated with acquiring biopharmaceutical drugs act as a major hindrance. Secondly, the substantial capital investment required for the production of active pharmaceutical ingredients (APIs) serves as a significant restraint that could impede the market's growth.

Market Trends

The cost incurred by the nation's healthcare system due to heart disease is on the rise. An important trend observed in the pharmaceutical intermediates market is the increasing prevalence of chronic cardiovascular conditions like heart failure and coronary artery disease. A July 2020 paper published in the Curious Journal of Medical Science states that ischemic heart disease (IHD) ranks as the leading cause of death worldwide. Approximately 126 million people globally are affected by ischemic heart disease. The projections indicate that by 2030, there will be over 1,845 cases of ischemic heart disease per 100,000 individuals worldwide.

Product Code: SQMIG35I2111

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Pharmaceutical Intermediates Market by Product

Market Overview
Chemical intermediates
Bulk drug intermediates
and Custom intermediates

Global Pharmaceutical Intermediates Market by Application

Market Overview
Analgesics
Anti-inflammatory drug
Cardiovascular drugs
Anti-diabetic drugs
Anti-cancer drugs

Global Pharmaceutical Intermediates Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

BASF SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wuxi AppTec Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dishman Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Codexis Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cambrex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hikal Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chemcon Speciality Chemicals Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Porton Fine Chemicals Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Divis Laboratories Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer CentreOne
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aurobindo Pharma Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lianhe Chemical Technology Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jiangsu Hengrui Medicine Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shandong Xinhua Pharmaceutical Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi STA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zhejiang NHU Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

Global Pharmaceutical Intermediates Market Size, Share, Growth Analysis, By Product(Chemical intermediates, Bulk drug intermediates), By Application(Analgesics, Anti-inflammatory drug) - Industry Forecast 2023-2030